DFX Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
Borrower
M••••
Healthcare & Pharmaceuticalsgroup grade Aoff every schedule since Dec 31, 2025sponsor unattributed
Nothing material in the last 200 days. Last change: 31 Dec 2025, Consensus mark 110¢ on cost, up from 95¢ a year ago, 108¢ last quarter.
Mark path, consensus per quarter end
95¢ · 99¢ · 107¢ · 108¢ · 110¢Q4 2024 to Q4 2025
Where each lender marks it on the unsecured or subordinated subordinated, 0 points apart
110¢110¢
Principal held
at least $11.3M
sum of BDC pieces, a lower bound
Fair value
$13.4M
110c on cost, debt pieces
Unfunded
Not disclosed
commitments not yet drawn
BDC lenders
2
2 on the latest quarter
Facilities
1
0 equity pieces beside them
Next maturity
Oct 4, 2032
no dated debt inside 24 months
On the tape since
Dec 31, 2024
latest Dec 31, 2025
Events
2
dated, non-routine
Lender marks
each lender's own fair value over cost at Dec 31, 2025, folded to one row per lender
| Lender | Exposure | Current mark | QoQ change |
|---|---|---|---|
| B••• C•••••• P•••••• C••••• | $5.67M | 110¢ | +2 pts |
| B••• C•••••• S•••••••• F••••••• I••• | $5.67M | 110¢ | +2 pts |
Every BDC piece · 2 positions across 2 lenderslargest principal first, with instrument and rate
| BDC | Instrument | Principal | Fair value | Rate |
|---|---|---|---|---|
| B••• C•••••• P•••••• C••••• | subordinated debt unsecured or subordinated S••••••••• D••• E•••••• S••••• 9.25% (0.75% PIK) I••••••• R••• 12.23% M••••••• D••• 10/4/2 | $5.7M | $6.7M 110c | //www.baincapital.com/20260630#Euro Interbank Offered Rate+925 bp PIK 0.75% |
| B••• C•••••• S•••••••• F••••••• I••• | subordinated debt unsecured or subordinated S••••••••• D••• E•••••• S••••• 9.25%(10.00% PIK) I••••••• R••• 12.23% M••••••• D••• 10/4/2 | $5.7M | $6.7M 110c | //www.baincapital.com/20260630#Euro Interbank Offered Rate+925 bp PIK 0.75% |
Capital structure as the BDCs see it
latest quarter end Dec 31, 2025
| Facility | Held | On cost | Pricing | Maturity | BDCs |
|---|---|---|---|---|---|
| unsecured or subordinated subordinated debt unsecured or subordinated exited Dec 31, 2025 | at least $11.3M | 110c | //www.baincapital.com/20260630#Euro Interbank Offered Rate+925 bp PIK 0.75% | Oct 4, 2032 | 2 |
Through time
the borrower's pieces summed across BDCs, every quarter end
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Dec 31, 2025 | 2 | $11.3M | $13.4M | 110c | 2 |
| Sep 30, 2025 | 2 | $10.7M | $12.4M | 108c | 2 |
| Jun 30, 2025 | 2 | $10.7M | $12.3M | 107c | 2 |
| Mar 31, 2025 | 2 | $10.0M | $10.5M | 99c | 1 |
All 5 quartersShow fewer
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Dec 31, 2024 | 2 | $15.0M | $15.3M | 95c | 3 |
What changed
- Facility left every BDC scheduleDec 31, 2025
- PIK interest appearsJun 30, 2025
- New borrower on a BDC scheduleDec 31, 2024
Sponsor
No sponsor attribution: no portfolio page, deal announcement or Form D signer consensus names an owner for this borrower group.
Identity
- Group key
- MASCOderivedthe codename stem after legal suffixes and deal words
- Spellings
- 1 across 2 BDCsderived
- Industry
- Healthcare & Pharmaceuticalsreportedas one filer wrote it